Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · IEX Real-Time Price · USD
0.642
-0.018 (-2.79%)
At close: May 2, 2024, 3:58 PM
0.649
+0.007 (1.14%)
After-hours: May 2, 2024, 7:37 PM EDT

Traws Pharma Revenue

In the year 2023, Traws Pharma had annual revenue of $226.00K. Revenue in the quarter ending December 31, 2023 was $56.00K.

Revenue (ttm)
$226.00K
Revenue Growth
n/a
P/S Ratio
71.83
Revenue / Employee
$13,294
Employees
17
Market Cap
16.23M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023226.00K--
Dec 31, 2022226.00K--
Dec 31, 2021226.00K-5.00K-2.16%
Dec 31, 2020231.00K-1.95M-89.42%
Dec 31, 20192.18M955.00K77.77%
Dec 31, 20181.23M441.00K56.04%
Dec 31, 2017787.00K-4.76M-85.81%
Dec 31, 20165.55M-5.91M-51.59%
Dec 31, 201511.46M10.66M1,332.00%
Dec 31, 2014800.00K-3.95M-83.17%
Dec 31, 20134.75M-41.44M-89.71%
Dec 31, 201246.19M44.70M3,006.25%
Dec 31, 20111.49M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareCloud 117.06M
Flora Growth 76.07M
Streamline Health Solutions 22.60M
Avalo Therapeutics 1.92M
Talphera 651.00K
QT Imaging Holdings 40.36K
Revenue Rankings